1. Home
  2. VRNA vs AKR Comparison

VRNA vs AKR Comparison

Compare VRNA & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • AKR
  • Stock Information
  • Founded
  • VRNA 2005
  • AKR 1993
  • Country
  • VRNA United Kingdom
  • AKR United States
  • Employees
  • VRNA N/A
  • AKR 117
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • AKR Real Estate Investment Trusts
  • Sector
  • VRNA Health Care
  • AKR Real Estate
  • Exchange
  • VRNA Nasdaq
  • AKR Nasdaq
  • Market Cap
  • VRNA 3.4B
  • AKR 2.9B
  • IPO Year
  • VRNA 2017
  • AKR 1993
  • Fundamental
  • Price
  • VRNA $48.46
  • AKR $23.84
  • Analyst Decision
  • VRNA Strong Buy
  • AKR Buy
  • Analyst Count
  • VRNA 6
  • AKR 4
  • Target Price
  • VRNA $43.83
  • AKR $23.00
  • AVG Volume (30 Days)
  • VRNA 854.0K
  • AKR 1.8M
  • Earning Date
  • VRNA 02-27-2025
  • AKR 02-11-2025
  • Dividend Yield
  • VRNA N/A
  • AKR 3.06%
  • EPS Growth
  • VRNA N/A
  • AKR N/A
  • EPS
  • VRNA N/A
  • AKR 0.10
  • Revenue
  • VRNA $5,624,000.00
  • AKR $367,395,000.00
  • Revenue This Year
  • VRNA N/A
  • AKR N/A
  • Revenue Next Year
  • VRNA $644.06
  • AKR $5.54
  • P/E Ratio
  • VRNA N/A
  • AKR $231.97
  • Revenue Growth
  • VRNA 1127.95
  • AKR 7.51
  • 52 Week Low
  • VRNA $11.39
  • AKR $16.10
  • 52 Week High
  • VRNA $47.29
  • AKR $26.29
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 71.27
  • AKR 40.82
  • Support Level
  • VRNA $45.05
  • AKR $23.60
  • Resistance Level
  • VRNA $47.29
  • AKR $24.26
  • Average True Range (ATR)
  • VRNA 2.21
  • AKR 0.47
  • MACD
  • VRNA 0.45
  • AKR -0.08
  • Stochastic Oscillator
  • VRNA 100.00
  • AKR 24.22

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company's portfolios are located primarily in metropolitan areas of the United States. The company operates through three segments: core portfolio, which consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon and generates the majority of total revenue; funds, which comprises the funds launched by the trust; and structured financing, which consists of notes receivable and related interest income.

Share on Social Networks: